STAAR Surgical Co
NASDAQ:STAA
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
US |
STAAR Surgical Co
NASDAQ:STAA
|
2.1B USD | 51.8 | ||
CH |
Alcon AG
SIX:ALC
|
39.4B CHF | 31.3 | ||
JP |
Hoya Corp
TSE:7741
|
6.3T JPY | 30.9 | ||
DK |
Coloplast A/S
CSE:COLO B
|
188.9B DKK | 34.2 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
20.9B USD | 26.6 | ||
US |
Cooper Companies Inc
NYSE:COO
|
19B USD | 33.8 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
12.3T KRW | -110.1 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
60.5B CNY | 40.3 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 18.4 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 13.8 | ||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 16.8 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.